27 April 2022 - NICE has published evidence-based recommendations on the use of tucatinib for the treatment of adults with ...
27 April 2022 - NICE has published evidence-based recommendations on the use of venetoclax in combination with low dose cytosine ...
20 April 2022 - This is the first appraisal of nivolumab to be terminated by NICE. ...
14 April 2022 - An innovative and potentially life-extending drug for treating people with a specific gene mutation of advanced ...
7 April 2022 - The Department of Health and Social Care has asked NICE to produce guidance on the use ...
13 April 2022 - NICE has published evidence based recommendations on the use of daratumumab (Darzalex) for the treatment of ...
7 April 2022 - NICE has today issued draft guidance which does not recommend sacituzumab govitecan for treating locally advanced or ...
7 April 2022 - Over 800 people with locally advanced or metastatic urothelial cancer are set to benefit from a new ...
30 March 2022 - Tagraxofusp is human interleukin-3 genetically conjugated to diphtheria toxin protein. ...
24 March 2022 - NICE has published evidence-based recommendations on nivolumab (Opdivo) with ipilimumab (Yervoy) for untreated advanced renal cell ...
21 March 2022 - The NICE method guide for technology appraisals encourages medicine manufacturers to use the EuroQol 5 Dimension in ...
18 March 2022 - A targeted new drug for a rare and aggressive form of lung cancer will be fast-tracked ...
16 March 2022 - NICE has published evidence-based recommendations on the use of dostarlimab (Jemperli) for the treatment of adults ...
15 March 2022 - A life-extending injection for a fatal form of blood cancer will be available to around 350 ...
9 March 2022 - NICE is unable to make a recommendation on the use of lenalidomide for the treatment of patients ...